ES2180579T3 - Transferencia de genes en celulas epiteliales pancreaticas. - Google Patents
Transferencia de genes en celulas epiteliales pancreaticas.Info
- Publication number
- ES2180579T3 ES2180579T3 ES94916720T ES94916720T ES2180579T3 ES 2180579 T3 ES2180579 T3 ES 2180579T3 ES 94916720 T ES94916720 T ES 94916720T ES 94916720 T ES94916720 T ES 94916720T ES 2180579 T3 ES2180579 T3 ES 2180579T3
- Authority
- ES
- Spain
- Prior art keywords
- epithelial cells
- transfer
- genes
- pancreatic epithelial
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4712—Cystic fibrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A LOS METODOS PARA LA TRANSFERENCIA GENETICA SOMATICA Y SELECTIVA A LAS CELULAS EPITELIALES PANCREATICAS O BILIARES DE UN PACIENTE. EL METODO DE ESTA INVENCION COMPRENDE LA INTRODUCCION DEL GEN QUE HA DE TRANSFERIRSE, ASOCIADO CON UN VEHICULO DE TRANSFERENCIA APROPIADO, EN EL SISTEMA DUCTAL TANTO DEL PANCREAS COMO DEL HIGADO. DE FORMA MAS ESPECIFICA, LA INVENCION SE REFIERE A LA APLICACION DE ESTAS TECNICAS PARA TRATAR LAS ENFERMEDADES GENETICAS, COMO LA FIBROSIS QUISTICA, QUE SE CARACTERIZAN POR DEFECTOS GENETICOS DE ESTAS CELULAS EPITELIALES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5989993A | 1993-05-10 | 1993-05-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2180579T3 true ES2180579T3 (es) | 2003-02-16 |
Family
ID=22026003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94916720T Expired - Lifetime ES2180579T3 (es) | 1993-05-10 | 1994-05-10 | Transferencia de genes en celulas epiteliales pancreaticas. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20050048043A1 (es) |
EP (2) | EP1211319A2 (es) |
JP (1) | JPH08509869A (es) |
AT (1) | ATE221575T1 (es) |
AU (1) | AU6829994A (es) |
CA (1) | CA2162602A1 (es) |
DE (1) | DE69431106T2 (es) |
DK (1) | DK0698109T3 (es) |
ES (1) | ES2180579T3 (es) |
PT (1) | PT698109E (es) |
WO (1) | WO1994026915A1 (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2705686B1 (fr) * | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
US5846782A (en) | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
US6465253B1 (en) | 1994-09-08 | 2002-10-15 | Genvec, Inc. | Vectors and methods for gene transfer to cells |
US6107027A (en) * | 1994-12-14 | 2000-08-22 | University Of Washington | Ribozymes for treating hepatitis C |
US6127525A (en) * | 1995-02-21 | 2000-10-03 | Cornell Research Foundation, Inc. | Chimeric adenoviral coat protein and methods of using same |
US5770442A (en) * | 1995-02-21 | 1998-06-23 | Cornell Research Foundation, Inc. | Chimeric adenoviral fiber protein and methods of using same |
US5837693A (en) * | 1995-03-24 | 1998-11-17 | The Regents Of The University Of California | Intravenous hormone polypeptide delivery by salivary gland expression |
US5885971A (en) * | 1995-03-24 | 1999-03-23 | The Regents Of The University Of California | Gene therapy by secretory gland expression |
US6531455B1 (en) | 1995-03-24 | 2003-03-11 | The Regents Of The University Of California | Delivery of polynucleotides by secretory gland expression |
US5830878A (en) | 1995-06-07 | 1998-11-03 | Megabios Corporation | Cationic lipid: DNA complexes for gene targeting |
US7011976B1 (en) | 1997-03-03 | 2006-03-14 | Calydon, Inc. | Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
US6254862B1 (en) | 1997-03-03 | 2001-07-03 | Calydon, Inc. | Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
WO1997005898A1 (en) * | 1995-08-03 | 1997-02-20 | The Johns Hopkins University School Of Medicine | Delivery of an agent to the ductal epithelium in the prophylactic and therapeutic treatment of cancer |
US5763415A (en) * | 1995-08-03 | 1998-06-09 | John Hopkins University School Of Medicine | Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer |
CA2229287A1 (en) * | 1995-08-14 | 1997-02-27 | Cornell Research Foundation, Inc. | Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
CA2179341A1 (en) * | 1996-04-12 | 1997-10-13 | Gregory S. Korbutt | Methods for isolating, enriching and increasing the maturation of cells |
AU5926998A (en) * | 1997-01-21 | 1998-08-07 | Wisconsin Alumni Research Foundation | Treatment of diabetes with synthetic beta cells |
US6352857B1 (en) | 1997-01-21 | 2002-03-05 | Wisconsin Alumni Research Foundation | Treatment of diabetes with synthetic beta cells |
US6056687A (en) * | 1997-12-04 | 2000-05-02 | American Medical Systems, Inc. | Device for alleviating urinary incontinence |
US20030017138A1 (en) | 1998-07-08 | 2003-01-23 | Menzo Havenga | Chimeric adenoviruses |
US6030337A (en) * | 1998-07-30 | 2000-02-29 | American Medical Systems, Inc. | Continence augmentor and methods for urinary control |
US6929946B1 (en) | 1998-11-20 | 2005-08-16 | Crucell Holland B.V. | Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
US6492169B1 (en) | 1999-05-18 | 2002-12-10 | Crucell Holland, B.V. | Complementing cell lines |
US6913922B1 (en) | 1999-05-18 | 2005-07-05 | Crucell Holland B.V. | Serotype of adenovirus and uses thereof |
AU2001268373A1 (en) * | 2000-06-13 | 2001-12-24 | The Children's Hospital Of Philadelphia | Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus |
DE60138403D1 (de) | 2000-09-26 | 2009-05-28 | Crucell Holland Bv | Adenovirale vektoren für die übertragung von genen in zellen der skelettmuskulatur oder myoblasten |
JP2004532822A (ja) * | 2001-03-14 | 2004-10-28 | アビジェン, インコーポレイテッド | ビリオンの管逆行感染による組換えアデノ随伴ウイルス媒介遺伝子移入 |
JP2003189875A (ja) * | 2001-12-28 | 2003-07-08 | Japan Science & Technology Corp | 膵β細胞関連転写因子の遺伝子導入によるインスリン産生細胞の形成誘導 |
ES2335657T3 (es) | 2002-04-25 | 2010-03-31 | Crucell Holland B.V. | Medios y metodos para la produccion de vectores de adenovirus. |
RU2468765C1 (ru) * | 2011-09-02 | 2012-12-10 | Радик Рашитович Хафизов | Устройство для однопортовой лапароскопической санации, дренирования сальниковой сумки, брюшной полости при деструктивных формах острого панкреатита |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4755167A (en) * | 1984-04-10 | 1988-07-05 | Research Corporation | In vivo method for distribution and stirring of therapeutic agents |
EP0228458B2 (en) * | 1985-07-05 | 1997-10-22 | Whitehead Institute For Biomedical Research | Epithelial cells expressing foreign genetic material |
DE3751863T2 (de) * | 1986-05-20 | 1996-12-12 | Gen Hospital Corp | Bestimmung der Insulin Expression |
US5166320A (en) * | 1987-04-22 | 1992-11-24 | University Of Connecticut | Carrier system and method for the introduction of genes into mammalian cells |
US5328470A (en) * | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
US5240846A (en) * | 1989-08-22 | 1993-08-31 | The Regents Of The University Of Michigan | Gene therapy vector for cystic fibrosis |
CA2112375A1 (en) * | 1991-06-28 | 1993-01-07 | Elizabeth G. Nabel | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
ATE237694T1 (de) * | 1991-08-20 | 2003-05-15 | Us Gov Health & Human Serv | Adenovirus vermittelter gentransfer in den gastrointestinaltrakt |
US5885971A (en) * | 1995-03-24 | 1999-03-23 | The Regents Of The University Of California | Gene therapy by secretory gland expression |
-
1994
- 1994-05-10 WO PCT/US1994/005187 patent/WO1994026915A1/en active IP Right Grant
- 1994-05-10 AT AT94916720T patent/ATE221575T1/de not_active IP Right Cessation
- 1994-05-10 DE DE69431106T patent/DE69431106T2/de not_active Expired - Fee Related
- 1994-05-10 JP JP6525647A patent/JPH08509869A/ja active Pending
- 1994-05-10 AU AU68299/94A patent/AU6829994A/en not_active Abandoned
- 1994-05-10 DK DK94916720T patent/DK0698109T3/da active
- 1994-05-10 PT PT94916720T patent/PT698109E/pt unknown
- 1994-05-10 EP EP01129457A patent/EP1211319A2/en not_active Withdrawn
- 1994-05-10 ES ES94916720T patent/ES2180579T3/es not_active Expired - Lifetime
- 1994-05-10 EP EP94916720A patent/EP0698109B1/en not_active Expired - Lifetime
- 1994-05-10 CA CA002162602A patent/CA2162602A1/en not_active Abandoned
-
2004
- 2004-10-08 US US10/961,625 patent/US20050048043A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69431106T2 (de) | 2003-05-08 |
CA2162602A1 (en) | 1994-11-24 |
DK0698109T3 (da) | 2002-11-25 |
EP1211319A2 (en) | 2002-06-05 |
DE69431106D1 (de) | 2002-09-05 |
EP0698109B1 (en) | 2002-07-31 |
JPH08509869A (ja) | 1996-10-22 |
PT698109E (pt) | 2002-12-31 |
EP0698109A1 (en) | 1996-02-28 |
ATE221575T1 (de) | 2002-08-15 |
US20050048043A1 (en) | 2005-03-03 |
WO1994026915A1 (en) | 1994-11-24 |
AU6829994A (en) | 1994-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2180579T3 (es) | Transferencia de genes en celulas epiteliales pancreaticas. | |
DE69121618D1 (de) | Mutierte Luciferase vom Leuchtkäfer, mutiertes Luciferasegen, rekombinante DNS diese Gene enthaltend, und Verfahren zur Herstellung von mutierter Luciferase | |
PT868505E (pt) | Inducao condrogenica in vitro de celulas estaminais mesenquimais humanas | |
PT1019428E (pt) | Oligonucleotidos hibridos e quimericos invertidos | |
AU5121399A (en) | Rna targeted 2'-modified oligonucleotides that are conformationally preorganized | |
DK0973928T3 (da) | DNA-baseret transposonsystem til indføring af nukleinsyre i DNA i en celle | |
BR9510003B1 (pt) | moléculas não naturais de dna enzimático e método de preparação. | |
WO1999057322A3 (en) | Genotyping the human udp-glucuronosyltransferase 1 (ugt1) gene | |
DE69925856D1 (de) | Verfahren zur klonierung von schweinen | |
DK0948255T3 (da) | Forbedret chondrogen differentiering af humane mesenkymale stamceller | |
NO175964C (no) | Analogifremgangsmåte til fremstilling av en terapeutisk aktiv, platinaholdig, makromolekylær, kompleks sammensetning | |
IL181695A0 (en) | Methods for cultivating cells and propagating viruses | |
WO1997003192A3 (en) | Chromosome 1 gene and gene products related to alzheimer's disease | |
AU5314294A (en) | Improvements in or relating to organic compounds | |
EP1331264A4 (en) | PROCESS FOR CULTURING HUMAN CHONDROCYTES | |
DK0986568T3 (da) | Kationiske midler til transfektion af nukleinsyrer | |
EP0763205A4 (en) | NUCLEIC ACID SEQUENCES REGULATING THE EXPRESSION OF LUNG SPECIFIC GENES | |
EP0444664A3 (en) | Fusaric acid resistant genes | |
AU6471899A (en) | Parvovirus vectors and their use | |
ATE159048T1 (de) | Modifizierung des zellmetabolismus durch extrazellulöse nukleasen | |
AU7771100A (en) | Development of an effective gene transfer technique for introducing foreign dna into sperm cells | |
Lee et al. | Studies on the Transfection System of Keratinocyte Using P Transposon Vector for Gene Therapy |